Investing in pharmaceuticals
Market volatility brings traditionally defensive stocks like pharmaceuticals into focus for investors. Jeremy Batstone-Carr, director of research at Charles Stanley, looks at some plays and the difference between the sector’s giants and the minnows
More like this
- Home
- Trading
- Investing
- Tools & Research
- News & Opinion
- Everyday Money
Search iiTV
About the expert
Jeremy Batstone-Carr is Chief Economist & Strategist at Charles Stanley responsible for global asset allocation and investment strategy. He joined Charles Stanley in 2004 having been Head of Research at NatWest Stockbrokers, Fyshe Group and Coutts. Jeremy lectures widely and is the Chairman of the Securities Institute investment analysis exam.
Ask our experts
Our Take Two experts will answer any of your questions. If there’s a burning issue you want answers to, send it to us and we will get our experts on the case

